Home › Scleroderma › Pennsylvania › Philadelphia
Scleroderma clinical trials in Philadelphia, PA
6 studies for Scleroderma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
RecruitingPhase 2
- Perelman Center for Advanced Medicine, Philadelphia
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
RecruitingPhase 3
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RecruitingPhase 2/3
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RecruitingPhase 1
- Jefferson Einstein Hospital Philadelphia, Philadelphia
Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
RecruitingPhase 2
- Children's Hospital of Philadelphia, Philadelphia
About Scleroderma
Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.
More about Scleroderma on MedlinePlus
Scleroderma trials in other cities
- New York City, NY11 studies
- Chicago, IL10 studies
- Ann Arbor, MI10 studies
- Houston, TX9 studies
- Durham, NC7 studies
- Los Angeles, CA7 studies
- Boston, MA7 studies
- Baltimore, MD6 studies
- New Orleans, LA6 studies
- Pittsburgh, PA5 studies
- Dallas, TX5 studies
- Edison, NJ4 studies
Other studies in Philadelphia
- Cancer (all types)60 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma26 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.